- Reliq Health, a high-growth health tech stock, has signed six new contracts in the United States.
- The contracts include physician practices in California, Florida and Nevada and are expected to add more than 3,000 new patients to Reliq’s iUGO Care platform
- Total revenue is estimated at $65 per patient per month at a 75 per cent gross margin
- Reliq Health Technologies is a healthcare technology company specializing in virtual care solutions
- Reliq Health Technologies (TSXV:RHT) last traded at $0.52 per share
Reliq Health, a high-growth health tech stock, has signed six new contracts in the United States.
The contracts include physician practices in California, Florida and Nevada and are expected to add over 3,000 new patients to the company’s iUGO Care platform by the end of Q1 2024.
The company expects to earn average revenue of $65 per patient per month at a 75 per cent gross margin.
All six practices go live in July.
“The southern U.S. states are a particularly attractive market segment for Reliq due to demographics. With many older Americans choosing to move south in retirement, there is a very large population of Medicare-covered patients in these states who are eligible for Reliq’s services,” stated Lisa Crossley, CEO of Reliq Health.
“The three states where we have the largest number of patients – California, Florida and Texas – make up over 25 per cent of the total U.S. population, with over 90 million residents,” she added.
Reliq Health Technologies is a healthcare technology company specializing in virtual care solutions. We recently covered the highly prospective company on Anatomy of a Flagship Asset, which introduces you to the most promising projects and products creating value in the Canadian stock market.
Reliq Health Technologies (TSXV:RHT) last traded at $0.52 per share.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
